2Cutler CS, Lee S J, Greenberg P, et al. A decision analysis of allogeneic bone marrow transplantation foe the myelodysplastic syndromes : delayed transplantation for low risk myelodysplasia is associated with improved outcome[ J]. Blood,2004,104:579 - 585.
3Deeg H J, Storer B, Slattery JT, et al. Conditioning with targeted busulfan and cyclophosphomide for hematopoietic stem cell transplantation fromrelated and unrelated donors in patients with myelodysplastic syndrome[ J]. Blood ,2002,100:1201 - 1207.
4Locatelli F, Nollke P, Zecca M, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML) : results of the EWOG-MDS/EBMT trial [ J]. Blood ,2005,105:410 - 419.
5Guardiola P, Runde V, Bacigalupo A et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating faCtor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes [ J ]. Blood, 2002,99:4370 - 4378.
6de Witte T, Oosterveld M, Muus P. Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome [ J ]. Blood Rev, 2007,21 :49 -59.
7Lu DP, Dong LJ, Wu T, et al. Conditioning including antithymocyte HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation[J]. Blood ,2006,107:3065 - 3073.
8Chen Y,Liu K, Xu L, et al. HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome [ J/ OL]. Bone Marrow Transplant,2010.
9Rodrigo M, Simona I, Ronald B, et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes [ J ]. Blood ,2006,108:836 - 846.
10Kindwall-Keller T, Isola LM. The evolution of hematopoietie SCT in myelodysplastic syndrome [ J ], Bone Marrow Transplant, 2009, 43(8) :597 -609.
